Here, we describe the development and application of a robust ddPCR assay that can efficiently and reproducibly quantify the expression of full length AR (AR-FL), AR-V7, and AR-v567es in CTCs isolated from the peripheral blood of patients with prostate cancer. This evidence concerns the gene AR and prostate carcinoma.